Articles tagged "Donation"

2019 American Transplant Congress
Temporal Trends Following Uncontrolled Donation after Cardiac Death Kidney Transplantation: Implications for Normothermic Regional Perfusion?
R. A. Choudhury, K. Prins, D. Yoeli, H. B. Moore, T. L. Nydam
Transplant Surgery, University of Colorado, Aurora, CO
*Purpose: Kidney transplantation following uncontrolled donation after cardiac (uDCD) remains an underutilized resource in the United States when compared to controlled DCD (cDCD) which has…
2019 American Transplant Congress
Unusual Suspects: Real Time Physiological Evaluation of Stressors during Laparoscopic Donor Nephrectomy
C. A. Wilson¹, S. Chahine¹, S. Cristancho¹, S. Aquil², M. Mandurah², M. A. Levine², A. Sener²
¹, Psychology and Center for Education Research & Innovation, Western University, London, ON, Canada, ²Surgery, Western University, London, ON, Canada
*Purpose: Stress is an important physiological response influenced by cognitive and emotional state. Faculty surgeons must balance teaching with ensuring good patient outcomes. Electrodermal activity…
2019 American Transplant Congress
Renal Transplantation from a Living Donor with a Horseshoe Kidney
J. CHOI, J. Jung, J. Kim, H. Kwon, S. Shin, Y. Kim, D. Han
Division of Kidney & Pancreas Transplantation, Department of Surgery, Asan Medical Center, Seoul, Korea, Republic of
*Purpose: Horseshoe kidney is one of the most common urinary congenital abnormalities, with an incidence of 1 in 400 to 800. Because of complexity, the…
2019 American Transplant Congress
Effect of Renal Function on Asymmetric Dimethylarginine (ADMA) Homeostasis in Kidney Donors and Recipients
M. Y. Said¹, R. M. Douwes¹, M. van Londen¹, I. Minović¹, A. Frenay², M. H. de Borst¹, E. van den Berg¹, M. R. Heiner-Fokkema³, A. A. Kayacelebi⁴, A. Bollenbach⁴, H. van Goor⁵, G. J. Navis¹, D. Tsikas⁴, S. J. Bakker¹
¹Internal medicine, University Medical Center Groningen, Groningen, Netherlands, ²Gynecology and Obstetrics, Amsterdam University Medical Center, Amsterdam, Netherlands, ³Laboratory Medicine, University Medical Center Groningen, Groningen, Netherlands, ⁴Inst. of Toxicology, Core Unit Proteomics, Hannover Medical School, Hannover, Germany, ⁵Pathology and Medical Biology, University Medical Center Groningen, Groningen, Netherlands
*Purpose: ADMA is a methylated form of arginine and an endogenous nitric oxide synthase inhibitor. Plasma ADMA (pADMA) is known as a strong cardiovascular risk…
2019 American Transplant Congress
Recipient Predictors of Post-Donation End Stage Renal Disease in Living Kidney Donors
J. Wainright¹, A. Robinson¹, A. Wilk¹, D. Klassen², W. Cherikh¹, L. Cartwright¹, D. Stewart¹
¹Research, UNOS, Richmond, VA, ²UNOS, Richmond, VA
*Purpose: We studied associations between kidney transplant recipient diagnosis and other factors and development of ESRD among related living kidney donors (LKDs).*Methods: Using OPTN listing…
2019 American Transplant Congress
External Validation of the DCD-N Score and a Linear Prediction Model to Identify Potential Candidates for Donation after Circulatory Death: A Nation-Wide Cohort Study
M. F. Nijhoff¹, R. A. Pol¹, M. Volbeda¹, A. M. Kotsopoulos², J. P. Sonneveld³, J. van Dongen⁴, W. F. Abdo⁵, V. Silderhuis⁶, C. Moers¹
¹Surgery – Organ Donation and Transplantation, University Medical Center Groningen, Groningen, Netherlands, ²Department of Intensive Care Unit (ICU), Elisabeth Twee Steden Hospital, Tilburg, Netherlands, ³Department of ICU, Isala, Zwolle, Netherlands, ⁴Department of ICU, Catharina hospital, Eindhoven, Netherlands, ⁵Department of ICU, Radboud University Medical Center, Nijmegen, Netherlands, ⁶Department of ICU, Medisch Spectrum Twente, Enschede, Netherlands
*Purpose: Donation after circulatory death (DCD) is most often a controlled procedure after planned withdrawal of life-sustaining treatment (WLST) at an intensive care unit. In…
2019 American Transplant Congress
Incorporating Tangible Benefits into the Risk-Benefit Analysis of Living Organ Donation Decisions
M. Robin¹, S. Rasmussen², A. Saha², A. Eno², M. Waldram², D. Segev², M. Henderson²
¹University of Maryland, Baltimore, MD, ²Johns Hopkins University, Baltimore, MD
*Purpose: The risk-benefit framework currently used in living organ donation presumes all benefit is afforded to the recipient, whereas the donor only assumes risks. However,…
2019 American Transplant Congress
Donate HCV Trial: Transplanting Thoracic Organs from Hepatitis C Donors to Uninfected Patients
A. E. Woolley¹, S. K. Singh², H. J. Goldberg³, M. M. Givertz⁴, M. R. Mehra⁴, A. Coppolino, III⁵, V. Cheng¹, J. Fanikos⁶, D. P. Harrington⁷, H. R. Mallidi², L. R. Baden¹
¹Infectious Diseases, Brigham and Womens Hospital, Boston, MA, ²Cardiac and Thoracic Surgery, Brigham and Womens Hospital, Boston, MA, ³Pulmonary, Brigham and Womens Hospital, Boston, MA, ⁴Cardiology, Brigham and Womens Hospital, Boston, MA, ⁵Thoracic Surgery, Brigham and Womens Hospital, Boston, MA, ⁶Pharmacy, Brigham and Womens Hospital, Boston, MA, ⁷Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA
*Purpose: Given the need for thoracic organs and the high mortality of patients awaiting heart or lung transplantation, it is imperative to find ways to…
2019 American Transplant Congress
Transplant Outcomes of DCD Kidneys Recovered with vs. without Pre-Recovery Heparin Administration
J. Narvaez, L. Kayler
Division of Transplantation, University at Buffalo, Buffalo, NY
*Purpose: DCD kidney transplants are associated with higher rates of delayed graft function (DGF) and primary non-function (PNF) likely due to ischemic events during recovery.…
2019 American Transplant Congress
Two-Year, Single Center, Retrospective Review of Herbal Supplement Use in Living Kidney Donors
N. Persun¹, D. Johnson¹, A. Leonberg-Yoo², J. Bahrainwala², P. P. Reese², D. M. Collins³, M. Houston³, A. Naji⁴, J. Trofe-Clark¹
¹Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, ²Renal Division, Perelman School of Medicine, Univ. of Pennsylvania, Philadelphia, PA, ³Hospital of the University of Pennsylvania, Philadelphia, PA, ⁴Surgery, Perelman School of Medicine, Univ. of Pennsylvania, Philadelphia, PA
*Purpose: Herbal supplement use in the evaluation phase of live kidney donors (LKD) poses challenges to providers. No formal management guidelines exist. Herbal supplements can…